Publisher
Springer International Publishing
Reference7 articles.
1. Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316–329
2. Foley PB (2003) Beans, roots and leaves. A history of the chemical therapy of Parkinsonism. Tectum, Marburg
3. Halliday GM, Barker RA, Rowe DB (eds) (2011) Non-dopamine lesions in Parkinson’s disease. Oxford University Press, New York
4. Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E (2011) Priorities in Parkinson’s disease research. Nat Rev Drug Discov 10:377–393
5. Olanow CW et al (2009) A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med 361:1268–1278